etc-1002
Showing 1 - 10 of 10
Hypercholesterolemia Trial in United States (ETC-1002, Placebo)
Completed
- Hypercholesterolemia
- ETC-1002
- Placebo
-
Hartford, Connecticut
- +4 more
Mar 10, 2022
Hypercholesterolemia, Atherosclerotic Cardiovascular Diseases Trial in Worldwide (ETC-1002, Placebo)
Completed
- Hypercholesterolemia
- Atherosclerotic Cardiovascular Diseases
- ETC-1002
- Placebo
-
Huntsville, Alabama
- +103 more
Apr 24, 2020
Safety Evaluation of Escalating Doses Trial in Kalamazoo (ETC-1002)
Completed
- Safety Evaluation of Escalating Doses
- ETC-1002
-
Kalamazoo, MichiganJasper Clinic, Inc.
Mar 26, 2019
Hyperlipidemia, Type 2 Diabetes Trial in Miramar (ETC-1002, Placebo)
Completed
- Hyperlipidemia
- Type 2 Diabetes
- ETC-1002
- Placebo
-
Miramar, Florida(unnamed)
Mar 26, 2019
Hypercholesterolemia Trial in Indianapolis, Louisville, Richmond (ETC-1002, Placebo, Atorvastatin)
Completed
- Hypercholesterolemia
- ETC-1002
- +2 more
-
Indianapolis, Indiana
- +2 more
Mar 26, 2019
Hyperlipidemia Trial in United States (ETC-1002, Atorvastatin, Placebo)
Completed
- Hyperlipidemia
- ETC-1002
- +2 more
-
Anaheim, California
- +18 more
Mar 26, 2019
Hypercholesterolemia, Hypertension Trial in United States (ETC-1002, Placebo)
Completed
- Hypercholesterolemia
- Hypertension
- ETC-1002
- Placebo
-
Birmingham, Alabama
- +34 more
Mar 26, 2019
Hypercholesterolemia Trial in United States (ETC-1002, Placebo, Statin Therapy)
Completed
- Hypercholesterolemia
- ETC-1002
- +2 more
-
Muscle Shoals, Alabama
- +39 more
Mar 26, 2019